Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ribavirin preconception and first-trimester exposure pregnancy registry
ChiCTR2000028705Phase 4Not yet recruiting
- Sponsor
- Women's Hospital, School of Medicine, Zhejiang University
- Start
- Aug 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ribavirin in pregnancy, sponsored by Women's Hospital, School of Medicine, Zhejiang University. Primary endpoint: Congenital defect. Planned start Aug 2015; status: not yet recruiting.
02
Drugs
ribavirin
03
Conditions
pregnancy
Beyond the preview
Go deeper on ChiCTR2000028705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000028705.